Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes

Hers, 1956, Le mecanisme de la transformation de glucose en fructose par les vesicules seminales, Biochim Biophys Acta, 22, 202, 10.1016/0006-3002(56)90247-5 Van Heyningen, 1959, Formation of polyols by the lens of the rat with “sugar” cataract, Nature, 184, 194, 10.1038/184194b0 Kinoshita, 1981, Aldose reductase in diabetic cataracts, JAMA, 246, 257, 10.1001/jama.246.3.257 Gabbay, 1975, Hyperglycemia, polyol metabolism and complications of diabetes mellitus, Annu Rev Med, 26, 521, 10.1146/annurev.me.26.020175.002513 Yue, 1982, The effect of aldose reductase inhibition of motor nerve conduction velocity in diabetic rats, Diabetes, 31, 789, 10.2337/diabetes.31.9.789 Kikkawa, 1983, Effect of new aldose reductase inhibitor, (E)-3-carboxymethyl-5-(2E)-methyl-3-phenyl propylenylidine Prodamine (ONO-2235) on peripheral nerve disorders in streptozotocin in diabetic rats, Diabetologia, 24, 290, 10.1007/BF00282716 Handelsman, 1981, Clinical trial of an aldose reductase inhibitor in diabetic neuropathy, Diabetes, 30, 459, 10.2337/diabetes.30.6.459 Culebras, 1981, Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy; preliminary report, Arch Neurol, 38, 133, 10.1001/archneur.1981.00510020091017 Judzewitsch, 1983, Aldose reductase inhibition improves nerve conduction velocity in diabetic patients, N Engl J Med, 308, 119, 10.1056/NEJM198301203080302 Fagius, 1981, Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy—a clinical and neurophysiologic study, J Neurol Neurosurg Psychiatry, 44, 991, 10.1136/jnnp.44.11.991 Jaspan, 1983, Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: Relief of pain and improved somatic and autonomic nerve function, Lancet, 2, 758, 10.1016/S0140-6736(83)92296-1 Jaspen, 1985, Improvement in cardiac autonomic nerve dysfunction in diabetic patients with aldose reductase inhibitor therapy, Clin Research, 33, 433 Young, 1983, A controlled trial of Sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy, Diabetes, 32, 938, 10.2337/diabetes.32.10.938 Clarke, 1979, Diabetic autonomic neuropathy, Diabetologia, 17, 195, 10.1007/BF01235856 Sundkvist, 1981, Autonomic nervous function in asymptomatic diabetic patients with signs of peripheral neuropathy, Diabetes Care, 4, 529, 10.2337/diacare.4.5.529 Keen, 1959, Autonomic neuropathy in diabetes mellitus, Postgrad Med J, 35, 272, 10.1136/pgmj.35.403.272 Rundles, 1945, Diabetic neuropathy, Medicine, 24, 110, 10.1097/00005792-194505000-00001 Ewing, 1980, The natural history of diabetic autonomic neuropathy, Q J Med, 49, 95 Jaspan, 1985, Effects of Sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy, Am J Med, 79, 24, 10.1016/0002-9343(85)90507-8 Hosking, 1978, Diabetic autonomic neuropathy, Diabetes, 27, 1043, 10.2337/diab.27.10.1043 Foulds, 1981, Kinetics of an orally absorbed aldose reductase inhibitor, Sorbinil, Clin Pharmacol Ther, 30, 693, 10.1038/clpt.1981.222 Malone, 1984, Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by Sorbinil in insulin-dependent diabetic subjects, Diabetes, 33, 45, 10.2337/diabetes.33.1.45 Ewing, 1980, Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications, Ann Intern Med, 92, 308, 10.7326/0003-4819-92-2-308 Campbell, 1974, Testicular pain sensation in diabetic autonomic neuropathy, Br Med J, 2, 638, 10.1136/bmj.2.5920.638 Anders, 1983, Nocturnal penile rigidity measured by the snap-gauge band, J Urol, 129, 964, 10.1016/S0022-5347(17)52486-6 Towle, 1985, A comparison of multimodality evoked potentials, computed tomography findings and clinical data in brainstem vascular infarcts, 383 Chiappa, 1983, 227 Gupta, 1981, Spinal somatosensory conduction in diabetes, Neurology, 31, 841, 10.1212/WNL.31.7.841